The general safety record
Spirulina (Arthrospira platensis) has been consumed by humans for centuries and has been in commercial production since the 1970s. It has GRAS (Generally Recognised as Safe) status from the US FDA. Multiple clinical trials have administered 3–10 g/day for 3–6 months without safety signals in healthy adults. The broad safety record is well-established.
That said, “generally safe” does not mean “safe for everyone.” Below are the specific concerns, graded by evidence level.
Absolute contraindications
Phenylketonuria (PKU)
Do not use spirulina if you have PKU. Phenylketonuria is a genetic disorder that impairs metabolism of phenylalanine, an amino acid. Spirulina is approximately 55–70% protein by weight and contains all essential amino acids including significant phenylalanine. Spirulina supplementation can cause serious harm in people with PKU who do not manage their phenylalanine intake.
Conditions requiring medical guidance before use
Autoimmune conditions
Spirulina polysaccharides stimulate immune function — particularly NK cell activity and macrophage activation. For most people this is beneficial. For people with autoimmune conditions (lupus, rheumatoid arthritis, multiple sclerosis, Hashimoto’s thyroiditis, inflammatory bowel disease), immune stimulation can exacerbate the overactive immune response driving the condition.
This is a theoretical concern with some mechanistic plausibility, not a documented pattern of harm in trials. But given the stakes, anyone with an autoimmune diagnosis should discuss spirulina with their specialist before starting.
Thyroid conditions
Spirulina is not a high-iodine food relative to seaweed, but it does contain iodine (approximately 15–50 µg per 3 g, varying by source). For people with managed thyroid conditions on stable medication, this is generally not significant. For people with thyroid conditions that are sensitive to iodine fluctuation (certain types of hyperthyroidism, particularly Graves’ disease), it is worth discussing with your endocrinologist.
Kidney disease
Spirulina’s high protein content means it generates urea as a metabolic byproduct. For people with advanced chronic kidney disease who require protein restriction, spirulina at typical doses adds a meaningful protein load. This is relevant at stage 3–5 CKD; mild kidney impairment is generally not a concern at 1–3 g/day.
Drug interactions
Anticoagulants (warfarin, apixaban, rivaroxaban)
Spirulina contains vitamin K (approximately 25 µg per 3 g) and has some mild antiplatelet activity. The vitamin K content is not high compared to dark leafy greens, but consistent daily supplementation could affect INR stability in warfarin users. If you are on warfarin, keep spirulina dose consistent (don’t start and stop) and inform your anticoagulation clinic. For newer anticoagulants (DOACs) the interaction is less established but worth noting.
Immunosuppressants (tacrolimus, ciclosporin, mycophenolate)
Spirulina’s immune-stimulating polysaccharides theoretically work against immunosuppressant medications taken to prevent organ transplant rejection or manage autoimmune conditions. This is a pharmacological direction conflict. Do not take spirulina alongside immunosuppressant therapy without specialist guidance.
Diabetes medications
Several trials have documented that spirulina modestly reduces fasting blood glucose. If you are on insulin or oral hypoglycaemics (metformin, sulfonylureas, SGLT2 inhibitors), the combined glucose-lowering effect may require dose adjustment. Monitor blood glucose more closely when starting spirulina, and discuss with your diabetes team. See the blood sugar article for the evidence detail.
Common side effects at typical doses
At 1–5 g/day in healthy adults, the documented side effects are mild and transient:
- Digestive discomfort in the first 1–2 weeks. Nausea, bloating, or loose stools when starting. This is the most commonly reported effect and typically resolves with gradual dose increase. Start at 0.5–1 g and build up over 2 weeks.
- Green or dark-coloured stools. Normal and expected — the chlorophyll and phycocyanin pigments transit through the gut. Not a sign of harm.
- Mild headache in the first few days. Reported by some users starting at higher doses (3 g+). Cause unclear — may be related to the detox-like process of increased antioxidant activity or simply the digestive adjustment.
Contamination as the largest real risk
The most significant safety risk from spirulina is not spirulina itself but contaminated spirulina. Poorly sourced products can contain:
- Heavy metals (lead, arsenic, mercury) at levels that cause harm over time — particularly relevant in pregnancy.
- Microcystins — hepatotoxic peptides from cyanobacteria that can co-contaminate spirulina cultivation.
Choosing a brand with published, batch-level, third-party CoA testing for heavy metals and microcystins addresses this risk substantially. See the quality guide and brand directory.
Pregnancy and breastfeeding
Clean, well-tested spirulina at 1–3 g/day is considered cautiously acceptable in pregnancy based on the available evidence. The full picture — including the Ngo-Matip 2015 RCT and the elevated quality standards required — is in the dedicated pregnancy guide.